Post-chemotherapy serum anti-müllerian hormone level predicts ovarian function recovery

Endocrine Connections
Hyun-Ah KimWoo Chul Noh

Abstract

In the era of precision medicine, the prediction of ovarian function recovery from chemotherapy-induced amenorrhoea using feasible biological markers may be helpful to optimise the treatment strategy for young patients with hormone receptor-positive breast cancer. The purpose of this study was to investigate the accuracy of post-chemotherapy biological markers for predicting the recovery of ovarian function in breast cancer patients of the ASTRRA trial, with chemotherapy-induced amenorrhoea. Using data of 82 participants from a single institution in the ASTRRA trial, the post-chemotherapy serum levels of the anti-müllerian hormone (AMH), estradiol, inhibin B, and other clinical factors associated with chemotherapy-induced amenorrhoea were evaluated. Recovery of ovarian function was defined by the resumption of menstruation manifested by vaginal bleeding. Fifty-two patients regained menstruation within 55 months after enrolment. In univariate analysis, <40 years of age (p=0.009), estradiol ≥37 pg/mL (p=0.003), or AMH ≥800 pg/mL (p=0.026) were associated with recovery of menstruation. On multivariate analysis, estradiol (hazard ratio: 3.171, 95% CI: 1.306-7.699, p=0.011) and AMH (hazard ratio: 2.853, 95% CI: 1.011-8.046, p=0.048)...Continue Reading

References

Nov 29, 2002·Human Reproduction·I A J van RooijA P N Themmen
May 2, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marianne NystedtLars Erik Rutqvist
Jun 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ian E SmithDaniel Hayes
May 30, 2007·British Journal of Cancer·K Lutchman SinghR Chatterjee
Apr 4, 2009·Fertility and Sterility·Mikkel RosendahlAnders Nyboe Andersen
Apr 22, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emanuela RossiAndrea de Matteis
Sep 8, 2009·Maturitas·Lynne T ShusterWalter A Rocca
Jul 10, 2010·The Breast : Official Journal of the European Society of Mastology·Eitan AmirMark Clemons
Feb 18, 2011·The Journal of Clinical Endocrinology and Metabolism·Richard A Anderson, David A Cameron
Aug 30, 2011·Reproductive Biomedicine Online·S M Nelson, A La Marca
Apr 25, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N L HenryD F Hayes
Dec 10, 2013·The Oncologist·N Lynn HenryDaniel F Hayes
Dec 19, 2013·International Journal of Endocrinology·Antonio La MarcaGeorg Griesinger
Mar 4, 2014·Breast Cancer Research and Treatment·Kathryn J RuddyAnn H Partridge
May 14, 2014·Human Reproduction Update·Simone L BroerBart C J M Fauser
Jul 17, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Joyce ChaiRichard A Anderson
Sep 24, 2014·Reproductive Biomedicine Online·Anne-Sophie HamyMarc Espié
Jan 31, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T FréourD Masson
Apr 22, 2017·Critical Reviews in Oncology/hematology·Giovanni Codacci-PisanelliFedro A Peccatori
May 4, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A DezellusT Freour
Nov 9, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R A AndersonR C F Leonard
Mar 17, 2018·Journal of the National Cancer Institute·Irene E G van HellemondUNKNOWN Dutch Breast Cancer Research Group (BOOG)

❮ Previous
Next ❯

Citations

Aug 10, 2020·The Journal of Clinical Endocrinology and Metabolism·Loes M E Moolhuijsen, Jenny A Visser
Jun 12, 2019·Clinical and Experimental Reproductive Medicine·So Ra OhYeon Jean Cho

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.